NeuroSense Therapeutics
NRSN
NRSN
5 hedge funds and large institutions have $132K invested in NeuroSense Therapeutics in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
5
Holders Change
-2
Holders Change %
-28.57%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
2
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Renaissance Technologies
New York
|
$97K |
| 2 |
2
Carson Wealth (CWM LLC)
Omaha,
Nebraska
|
$2K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $97K | +$97K | +54,300 | New |
|
|
VPIM
2
Vanguard Personalized Indexing Management
Oakland,
California
| $30K | -$41.9K | -23,102 | -58% |
|
3
UBS Group
Zurich,
Switzerland
| $3K | -$19K | -11,601 | -86% |
|
|
4
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| $2K | +$2K | +1,000 | New |
|
5
Jane Street
New York
| – | -$261K | -77,249 | Closed |
|
6
Citigroup
New York
| – | -$168K | -49,744 | Closed |
|
7
Millennium Management
New York
| – | -$68K | -20,259 | Closed |
|
|
TRCT
8
Tower Research Capital (TRC)
New York
| – | -$33K | -9,794 | Closed |
|
|
CS
9
Clear Street
New York
| – | -$24K | -7,157 | Closed |
|